1887
Volume 2011, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Ten patients with back pain and sciatica were selected according to certain inclusion criteria for a study to assess the efficacy of the Anti TNF agent Adalimumab in the treatment of refractory sciatica pain induced by a lumbar disc prolapse in patients who failed to improve following lumbar epidural steroid or disc surgery. Each was given a subcutaneous injection of 40mg Adalimumab repeated after two weeks. Patients were assessed regularly on weeks 0, 2, 4 and 8 employing the Visual Analogue Score (VAS) for leg pain and back pain and the Straight Leg Raising (SLR) test. The median improvement of the leg pain VAS was 55. Median improvements of back pain VAS was 37. Median improvement of the SLR was 45. The study demonstrated the beneficial effect of adalimumab therapy in reducing the back and leg pain associated with sciatica in this difficult to treat group of patients. The improvement of leg pain was more significant than that of back pain. The response was better in patients with symptoms of shorter duration and with less SLR restriction at base line.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2011.1.13
2011-06-01
2019-12-10
Loading full text...

Full text loading...

References

  1. Le Moitre CL, Hoyland JA, Freemont AJ. Catabolic Cytokine expression in degenerated and herniated human intervertebral discs: IL-lbeta and TNF-alpha expression profile. Arthritis Res Ther. 2007; 9:4:R77.
    [Google Scholar]
  2. Podichetty VK. The aging spine: The role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol. 2007; 53:5:418.
    [Google Scholar]
  3. Igarashi T, Kikuchi S, Shubayev V. Exogenous tumor necrosis factoralpha mimics nucleus pulposus-induced neuropathology: molecular, histologic, and behavioral comparisons in rats. Spine. 2000; 25::29752980.
    [Google Scholar]
  4. Modic MT, Ross JS. Lumbar degenerative disc disease. Radiology. 2007; 245:1:4361.
    [Google Scholar]
  5. Taylor PC, Williams RO, Feldmann F. Tumor necrosis factor as a therapeutic target for immune mediated inflammatory diseases. Curr Op Biotech. 2004; 15:6:557583.
    [Google Scholar]
  6. Mixter W. Rupture of the intervertebral disc with involvement of the spinal canal. NEJM. 1934; 211::210115.
    [Google Scholar]
  7. Peng B, et al., Chemical radiculitis. Pain. 2007; 127:1-2:1116.
    [Google Scholar]
  8. Aoki Y, Rydevik B, Kikuchi S. Local application of disc-related cytokines on spinal nerve roots. Spine. 2002; 27::16141617.
    [Google Scholar]
  9. Onda A, Yabuki S, Kikuchi S. Effects of neutralizing an tibodies to tumor necrosis factor-alpha on nucleus pulposus-induced abnormal nociresponses in rat dorsal horn neurons. Spine. 2003; 28::967972.
    [Google Scholar]
  10. Seguin CA, Pilliar RM, Roughley PJ. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine. 2005; 30:17:19401948.
    [Google Scholar]
  11. Mulleman D. Pathophysiology of disc related low back pain and sciatica. Evidence supporting treatment with TNF-alpha antagonists. Joint Bone Spine. 2006; 73:3:270277.
    [Google Scholar]
  12. Goupille P, Mulleman D, Valat JP. Radiculopathy associated with disc herniation. Ann Rheum Dis. 2006; 65::141143.
    [Google Scholar]
  13. Korhonen T, Karppinen J, Malmivaara A. Efficacy of infliximab for disc herniation-induced sciatica: One-year follow-up. Spine. 2004; 29::21152119.
    [Google Scholar]
  14. Korhonen T, Karppinen J, Paimela L. The treatment of disc herniationinduced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study. Spine. 2005; 30::27422748.
    [Google Scholar]
  15. Brennan S, Vanharanta H, Keenan A, et al., Treating sciatica with adalimumab: a pilot study EULAR 2004; Berlin, Germany. Abstract SAT. 2004; 0146:.
    [Google Scholar]
  16. Genevay S, Stingelin S, Gabay C. Efficacy of etanercept in the treatment of acute and severe sciatica: a pilot study. Ann Rheum Dis. 2004; 63::11201123.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2011.1.13
Loading
  • Article Type: Research Article
Keyword(s): Adalimumab , Anti TNF and Sciatica
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error